Imaging Surrogates of Infiltration Obtained Via Multiparametric Imaging Pattern Analysis Predict Subsequent Location of Recurrence of Glioblastoma

被引:115
作者
Akbari, Hamed [1 ,4 ]
Macyszyn, Luke [2 ,4 ]
Da, Xiao [1 ,4 ]
Bilello, Michel [1 ,2 ]
Wolf, Ronald L. [1 ]
Martinez-Lage, Maria [3 ]
Biros, George [5 ]
Alonso-Basanta, Michelle [6 ]
O'Rourke, Donald M. [2 ]
Davatzikos, Christos [1 ,4 ]
机构
[1] Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA
[3] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
[4] Univ Penn, Ctr Biomed Image Comp & Analyt, Philadelphia, PA 19104 USA
[5] Univ Texas Austin, Inst Computat Engn & Sci, Austin, TX 78712 USA
[6] Univ Penn, Dept Radiat Oncol, Philadelphia, PA 19104 USA
基金
美国国家卫生研究院;
关键词
Glioblastoma; Imaging pattern analysis; Infiltration; Multiparametric; Recurrence; CONFORMAL RADIOTHERAPY; VESSEL TORTUOSITY; MALIGNANT GLIOMA; BRAIN; ANGIOGENESIS; REGISTRATION; BIOMARKERS; FEATURES; PATIENT; EDEMA;
D O I
10.1227/NEU.0000000000001202
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BACKGROUND: Glioblastoma is an aggressive and highly infiltrative brain cancer. Standard surgical resection is guided by enhancement on postcontrast T1-weighted (T1) magnetic resonance imaging, which is insufficient for delineating surrounding infiltrating tumor. OBJECTIVE: To develop imaging biomarkers that delineate areas of tumor infiltration and predict early recurrence in peritumoral tissue. Such markers would enable intensive, yet targeted, surgery and radiotherapy, thereby potentially delaying recurrence and prolonging survival. METHODS: Preoperative multiparametric magnetic resonance images (T1, T1-gadolinium, T2-weighted, T2-weighted fluid-attenuated inversion recovery, diffusion tensor imaging, and dynamic susceptibility contrast-enhanced magnetic resonance images) from 31 patients were combined using machine learning methods, thereby creating predictive spatial maps of infiltrated peritumoral tissue. Cross-validation was used in the retrospective cohort to achieve generalizable biomarkers. Subsequently, the imaging signatures learned from the retrospective study were used in a replication cohort of 34 new patients. Spatial maps representing the likelihood of tumor infiltration and future early recurrence were compared with regions of recurrence on postresection follow-up studies with pathology confirmation. RESULTS: This technique produced predictions of early recurrence with a mean area under the curve of 0.84, sensitivity of 91%, specificity of 93%, and odds ratio estimates of 9.29 (99% confidence interval: 8.95-9.65) for tissue predicted to be heavily infiltrated in the replication study. Regions of tumor recurrence were found to have subtle, yet fairly distinctive multiparametric imaging signatures when analyzed quantitatively by pattern analysis and machine learning. CONCLUSION: Visually imperceptible imaging patterns discovered via multiparametric pattern analysis methods were found to estimate the extent of infiltration and location of future tumor recurrence, paving the way for improved targeted treatment.
引用
收藏
页码:572 / 580
页数:9
相关论文
共 39 条
[1]   Pattern Analysis of Dynamic Susceptibility Contrast-enhanced MR Imaging Demonstrates Peritumoral Tissue Heterogeneity [J].
Akbari, Hamed ;
Macyszyn, Luke ;
Da, Xiao ;
Wolf, Ronald L. ;
Bilello, Michel ;
Verma, Ragini ;
O'Rourke, Donald M. ;
Davatzikos, Christos .
RADIOLOGY, 2014, 273 (02) :502-510
[2]   Assessment of brain tumor angiogenesis inhibitors using perfusion magnetic resonance imaging: Quality and analysis results of a phase I trial [J].
Akella, NS ;
Twieg, DB ;
Mikkelsen, T ;
Hochberg, FH ;
Grossman, S ;
Cloud, GA ;
Nabors, LB .
JOURNAL OF MAGNETIC RESONANCE IMAGING, 2004, 20 (06) :913-922
[3]   Differentiation between vasogenic-edema versus tumor-infiltrative area in patients with glioblastoma during bevacizumab therapy: A longitudinal MRI study [J].
Artzi, Moran ;
Bokstein, Felix ;
Blumenthal, Deborah T. ;
Aizenstein, Orna ;
Liberman, Gilad ;
Corn, Benjamin W. ;
Ben Bashat, Dafna .
EUROPEAN JOURNAL OF RADIOLOGY, 2014, 83 (07) :1250-1256
[4]   Regional variation in histopathologic features of tumor specimens from treatment-naive glioblastoma correlates with anatomic and physiologic MR Imaging [J].
Barajas, Ramon F., Jr. ;
Phillips, Joanna J. ;
Parvataneni, Rupa ;
Molinaro, Annette ;
Essock-Burns, Emma ;
Bourne, Gabriela ;
Parsa, Andrew T. ;
Aghi, Manish K. ;
McDermott, Michael W. ;
Berger, Mitchel S. ;
Cha, Soonmee ;
Chang, Susan M. ;
Nelson, Sarah J. .
NEURO-ONCOLOGY, 2012, 14 (07) :942-954
[5]   Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas [J].
Brandsma, Dieto ;
Stalpers, Lukas ;
Taal, Walter ;
Sminia, Peter ;
van den Bent, Martinj .
LANCET ONCOLOGY, 2008, 9 (05) :453-461
[6]   Vessel tortuosity and brain tumor malignancy: A blinded study [J].
Bullitt, E ;
Zeng, DL ;
Gerig, G ;
Aylward, S ;
Joshi, S ;
Smith, JK ;
Lin, WL ;
Ewend, MG .
ACADEMIC RADIOLOGY, 2005, 12 (10) :1232-1240
[7]   LIBSVM: A Library for Support Vector Machines [J].
Chang, Chih-Chung ;
Lin, Chih-Jen .
ACM TRANSACTIONS ON INTELLIGENT SYSTEMS AND TECHNOLOGY, 2011, 2 (03)
[8]   Evaluation of peritumoral edema in the delineation of radiotherapy clinical target volumes for glioblastoma [J].
Chang, Eric L. ;
Akyurek, Serap ;
Avalos, Tedde ;
Rebueno, Neal ;
Spicer, Chris ;
Garcia, John ;
Famiglietti, Robin ;
Allen, Pamela K. ;
Chao, K. S. Clifford ;
Mahajan, Anita ;
Woo, Shiao Y. ;
Maor, Moshe H. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 68 (01) :144-150
[9]   Prospective Analysis of Parametric Response Map-Derived MRI Biomarkers: Identification of Early and Distinct Glioma Response Patterns Not Predicted by Standard Radiographic Assessment [J].
Galban, Craig J. ;
Chenevert, Thomas L. ;
Meyer, Charles R. ;
Tsien, Christina ;
Lawrence, Theodore S. ;
Hamstra, Daniel A. ;
Junck, Larry ;
Sundgren, Pia C. ;
Johnson, Timothy D. ;
Galban, Stefanie ;
Sebolt-Leopold, Judith S. ;
Rehemtulla, Alnawaz ;
Ross, Brian D. .
CLINICAL CANCER RESEARCH, 2011, 17 (14) :4751-4760
[10]   Diffusion Magnetic Resonance Imaging Detects Pathologically Confirmed, Nonenhancing Tumor Progression in a Patient With Recurrent Glioblastoma Receiving Bevacizumab [J].
Gerstner, Elizabeth R. ;
Frosch, Matthew P. ;
Batchelor, Tracy T. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (06) :E91-E93